DaSH Global (@DaSHGlobal2) header
DaSH Global (@DaSHGlobal2) profile picture

A leading real-world research company. Supporting the drug approval process by delivering cost-efficient, timely & unique real-world research data.

Congleton, UK
Joined March 2020
Photo by DaSH Global (@DaSHGlobal2)Photo by DaSH Global (@DaSHGlobal2)Photo by DaSH Global (@DaSHGlobal2)Photo by DaSH Global (@DaSHGlobal2)Photo by DaSH Global (@DaSHGlobal2)Photo by DaSH Global (@DaSHGlobal2)Photo by DaSH Global (@DaSHGlobal2)Photo by DaSH Global (@DaSHGlobal2)Photo by DaSH Global (@DaSHGlobal2)Photo by DaSH Global (@DaSHGlobal2)
Our next #Berkshire coffee morning is at 11AM tomorrow! See you there for a coffee and catch up ☕🍩@mesouk #charity #mesothelioma #support #asbestos #HASAG
3
6
188
Great day 1 of raising asbestos awareness #asbestos #mesothelioma @LondonLabour #CapeMustPay
Members of @LASAG_UK & @MerseysideAVS are representing us this week in Liverpool. We are here at The Labour Party Conference 2024 #LabourPartyConference, come & visit our pod where we are discussing current campaigns & issues surrounding asbestos in the UK. #asbestos
5
5
307
DaSH Global retweeted
Volunteer Opportunity: Join Our Medical & Scientific Advisory Panel ALK+ UK is looking for healthcare professionals or scientists, ideally with an interest in ALK-positive lung cancer, to join our advisory panel. This is a voluntary role, where your expertise will help shape our work in supporting patients, reviewing publications, and advising on clinical trials. If you’re a current or retired professional and can offer up to 10 hours a month, we’d love to hear from you. ALK-positive lung cancer is a relatively rare form of lung cancer that often affects younger people who are non-smokers. ALK Positive Lung Cancer UK UK is a registered charity that provides support and empowerment to ALK-positive lung cancer patients. We also advocate for best practices throughout the UK and campaign for early diagnosis of non-smoking lung cancer. @rcgp @BTOGORG @LCN_UK @UKlungcancer
1
3
9
444
Your Health Companion created in response to patients needing a tool to help them manage their condition. Register as a healthcare professional: health-companion.me/healthca… #Mesothelioma #LungCancer #Nurses #Clinicians #PatientAdvocacy #PatientOutcomes #NHS #Healthcare #CancerCare
3
4
149
The efficacy of almonertinib and anlotinib combination therapy for advanced non-small-cell lung cancer patients who continued to experience cancer progression during third-generation EGFR-TKI treatment: a retrospective study onlinelibrary.wiley.com/doi/…
8
13
1,088
#LungCancer patients often face challenges when it comes to travel ✈️ yet it can boost wellbeing & QOL. Our new webpage offers tips for managing medication & overcoming other travel hurdles. Plus advice to help make trips safe & enjoyable! egfrpositive.org.uk/travelli… #LCSM #EGFR
3
6
598
FRIDAY NEWS: VOICES OF LuCE Our #FridayNews this week comes from the UK where our members @UKALK1 & @LCN_UK presented a research poster at the Lung Cancer Nursing UK Annual Conference in Glasgow. 1/2
1
6
6
428
Lovely to see so many happy people at our Southampton coffee morning today, such a friendly supportive group, looking forward to next month already Mesothelioma UK #charity #support #mesothelioma
1
2
12
284
LCNUK would like to thank Professor Alison Leary, who is stepping down as a trustee of the charity, for her commitment to the role. We are grateful to Alison for her guidance and support of LCNUK over the years. Thank you!
2
12
242
Inclusion of quality-of-life metrics and patient-reported outcomes in lung cancer clinical trials is disappointingly and unacceptably low, as highlighted by Dr @pompili_cecilia at #ELIXR24.
1
17
2
47
11,876
Using @Health_Compan to collect health data is easy, convenient & secure: Providing accurate, personalised insights to support self-management, improve communication with your health team and opportunities for research. Download for free today: health-companion.me
1
2
69
Integrating Patient Reported Outcomes data into drug evaluation process can enhance understanding of a #cancer drug's benefits and risks, and ultimately accelerate access to new cancer drugs. By downloading Your Health Companion & recording your feedback - you can #drivechange
1
1
85
Data obtained from Patient Reported Outcomes Measures #PROMs and Patient Reported Experience Measures #PREMs collected via @Health_Compan delivers quantified, measured feedback invaluable for providing insights into the effectiveness, appropriateness & acceptability of therapies.
3
5
141
We're contesting #Mobocertinib's withdrawal in March - it's the only UK licensed TKI for #EGFR+ Exon 20 patients. Our case will be debated in @UKHouseofLords 14 Feb. New/existing patients can access until Mar. Existing via the @TakedaOncology compassionate use programme after.
4
12
509
Research will help @mesouk develop priorities and shape services going forward - directly benefiting people affected by #mesothelioma. #MakeYourExperienceCount mesothelioma.uk.com/experien… Sign up for Your Health Companion. health-companion.me/news-upd…
4
6
294
A recent survey of health teams using @Health_Compan in clinics - ALL respondents reported real benefits to them and their service of patients using Your Health Companion. 92% reporting it helps patients better manage their condition. Find out more health-companion.me
1
2
85
We're delighted to partner with @EgfrUk to support patients living with EGFR positive lung cancer to help manage their condition and drive research into non-smoking lung cancer. Download @Health_Compan today health-companion.me #BeInformed #SupportResearch #DriveChange
3
4
232
We collect Patient Reported Outcomes securely, continuously and accurately from patients nationally. Anonymised PROMS data helps drive #research into new treatments to improve the lives of those living with, and beyond, cancer. Add your voice. Sign up. health-companion.me
1
1
95
The @Health_Compan app has the potential to transform our conversations with patients with #LungCancer and improve the care we can deliver. If you are not yet participating in this programme, please consider getting involved in this important venture ➡️ ow.ly/9T2T50MhbF7
1
2
221